Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Legislation topic
No spam. Unsubscribe anytime.
PEBB staff monitors several bills that could affect costs, rebates and provider payments
Summary
PEBB staff briefed the board on several pending bills — including proposals affecting hospital payment caps and the distribution of pharmacy rebates — and said the agency is analyzing potential fiscal impacts.
PEBB staff reported to the board on March 25 that it is monitoring multiple 2025 legislative bills that could affect plan costs, rebate distribution or provider payments.
Celestina Glover highlighted a bill that would revise how hospitals and ambulatory surgical facilities are reimbursed (listed in materials as AB 349) and two Senate bills (SB 209 and SB 316) that would alter the application of pharmacy rebates. Glover said the hospital bill as currently written assumes direct contracting or a rate cap approach that PEBB does not use and that staff cannot yet compute a reliable fiscal impact without more detail about provider contracts. “We did not have the information, and we typically don't. We don't know what the various provider contracts say as far as their level of payments,” she said.
Glover explained the rebate bills would require rebates currently applied to overall plan costs to instead be applied to the individual member’s pharmacy costs. She warned that could reduce plan revenue and raise premiums for all members because the rebate dollars would no longer offset the plan’s gross costs. “However, what will happen is because we're losing those revenue streams, that would go into the expenditure side, which then would increase the rates across the board,” Glover said. Staff estimated the fiscal impact of the rebate proposals in materials at roughly $21–$23 million in the first biennium and up to about $46 million in future biennia, depending on how the bills are implemented.
Public comment and board members earlier also flagged other bills in public comment (AB 188, AB 169 and AB 349 were mentioned by public commenters as priorities). PEBB staff said it will continue to prepare fiscal analyses, work with vendors and testify as needed; staff indicated they typically testify in a neutral stance unless the board directs otherwise.
Why it matters: Proposals that change provider payment methods or redirect pharmacy rebates can shift costs between members and the plan and materially affect required state or employer contributions.
Next steps: Staff will continue analysis with Siegel and vendors (UMR, ESI) and return updates to the board as bills move through the legislature.
